The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia Hiroko IkedaEikichi IharaYoshihiro Ogawa Original Article—Alimentary Tract 12 March 2024 Pages: 361 - 375
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan Ken YamashitaShiro OkaShinji Tanaka Original Article—Alimentary Tract Open access 27 February 2024 Pages: 376 - 388
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis Daisuke HirayamaShinichiro HyodoHiroshi Nakase Original Article—Alimentary Tract Open access 16 March 2024 Pages: 389 - 401
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, randomized study Ho Suk KangSoo-Young NaJae Myung Cha Original Article—Alimentary Tract 16 March 2024 Pages: 402 - 410
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma Hao-Yang XinJi-Xue ZouShao-Lai Zhou Original Article―Liver, Pancreas, and Biliary Tract 10 March 2024 Pages: 411 - 423
Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy Kae NagaoArata SakaiYuzo Kodama Original Article―Liver, Pancreas, and Biliary Tract Open access 29 February 2024 Pages: 424 - 433
A revolutionary oral HBV treatment candidate as innovative therapeutic approach warranting clinical trials Takeshi Matsui Editorial 25 March 2024 Pages: 434 - 435
